LAP3 and amyotrophic lateral sclerosis: DPP4 is a peptidase that has previously been implicated in neurodegeneration in Alzheimer’s disease37, with DPP4 inhibition having shown beneficial outcomes in mouse models25, but it has not previously been connected with ALS.